These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24330901)

  • 1. Dr McGorry and colleagues reply.
    McGorry PD; Yung AR; Nelson B; Amminger GP; Phillips LJ
    J Clin Psychiatry; 2013 Nov; 74(11):1123. PubMed ID: 24330901
    [No Abstract]   [Full Text] [Related]  

  • 2. Biased reporting of results in patients at ultra-high risk of psychosis.
    Amos AJ
    J Clin Psychiatry; 2013 Nov; 74(11):1123. PubMed ID: 24330900
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome.
    McGorry PD; Nelson B; Phillips LJ; Yuen HP; Francey SM; Thampi A; Berger GE; Amminger GP; Simmons MB; Kelly D; Dip G; Thompson AD; Yung AR
    J Clin Psychiatry; 2013 Apr; 74(4):349-56. PubMed ID: 23218022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reply to "concern over your recent paper on risperidone long-acting injectable for treatment-resistant schizophrenia".
    Kanahara N; Kimura H; Iyo M
    Schizophr Res; 2016 May; 173(1-2):118. PubMed ID: 26971073
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of mental states at high risk for psychosis: preliminary results from Hungary].
    Kéri S; Kelemen O; Janka Z
    Orv Hetil; 2006 Feb; 147(5):201-4. PubMed ID: 16509220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficasy and safety of the use of risperidone (rispoluxe) in demented patients with psychotic and behavioural disorders].
    Bocharov AV; Kondakova VE; Tuleninov ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6):25-31. PubMed ID: 22983233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid risperidone in the treatment of psychotic agitation.
    Tsai C; Puzantian T
    CNS Drugs; 2002; 16(11):777; author reply 778. PubMed ID: 12383033
    [No Abstract]   [Full Text] [Related]  

  • 8. A report of successful treatment of psychosis in epilepsy with risperidone.
    Mahgoub NA
    J Neuropsychiatry Clin Neurosci; 2007; 19(3):347-8. PubMed ID: 17827431
    [No Abstract]   [Full Text] [Related]  

  • 9. Concerns over your recent paper on risperidone long-acting injectable for treatment-resistant schizophrenia.
    Kanaan RA
    Schizophr Res; 2015 Dec; 169(1-3):506. PubMed ID: 26560037
    [No Abstract]   [Full Text] [Related]  

  • 10. Risperidone in chorea and psychosis of Huntington's disease.
    Erdemoglu AK; Boratav C
    Eur J Neurol; 2002 Mar; 9(2):182-3. PubMed ID: 11882064
    [No Abstract]   [Full Text] [Related]  

  • 11. Risperidone depot in the treatment of psychosis associated with multiple sclerosis -- a case report.
    Hussain A; Belderbos S
    J Psychopharmacol; 2008 Nov; 22(8):925-6. PubMed ID: 18308807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone long-acting injection in practice - more questions than answers?
    Taylor D
    Acta Psychiatr Scand; 2006 Jul; 114(1):1-2. PubMed ID: 16774654
    [No Abstract]   [Full Text] [Related]  

  • 13. [The publication policy in Duodecim].
    Lehtinen V; Räkkölãinen V
    Duodecim; 1996; 112(3):228-9. PubMed ID: 10590634
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term relapse prevention with risperidone in 215 schizophrenic patients].
    Udina Abelló C; Roca Bennasar M; Octavio Del Valle I
    Actas Esp Psiquiatr; 2001; 29(4):243-9. PubMed ID: 11470059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic intervention for group with risk of psychosis--Sendai At-risk Mental State And First Episode].
    Matsumoto K; Miyakoshi T; Ito F; Omuro N; Matsuoka N
    Seishin Shinkeigaku Zasshi; 2009; 111(3):298-303. PubMed ID: 19499640
    [No Abstract]   [Full Text] [Related]  

  • 16. Risperidone for the treatment of monosymptomatic hypochondriacal psychosis.
    Cetin M; Ebrinç S; Ağargün MY; Yiğit S
    J Clin Psychiatry; 1999 Aug; 60(8):554. PubMed ID: 10485639
    [No Abstract]   [Full Text] [Related]  

  • 17. Preventing the onset of psychosis: not quite there yet.
    Heinssen RK; Insel TR
    Schizophr Bull; 2015 Jan; 41(1):28-9. PubMed ID: 25392518
    [No Abstract]   [Full Text] [Related]  

  • 18. Hospitalization risk in patients with schizophrenia before and after initiation of risperidone long-acting injection in Japan.
    Yoshimura B; Shinkawa I; Konishi A
    Asian J Psychiatr; 2015 Apr; 14():67-8. PubMed ID: 25736075
    [No Abstract]   [Full Text] [Related]  

  • 19. Hospitalisation and resource utilisation in patients with schizophrenia following initiation of risperidone long-acting therapy in the Veterans Affairs Healthcare System.
    Fuller M; Shermock K; Russo P; Secic M; Dirani R; Vallow S; Flanders S
    J Med Econ; 2009; 12(4):317-24. PubMed ID: 19817665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching between clozapine and risperidone treatment.
    Gardner DM; Baldessarini RJ; Benzo J; Zarate CA; Tohen M
    Can J Psychiatry; 1997 May; 42(4):430-1. PubMed ID: 9161773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.